Pharma rep laments being ignored and locked out by doctors
A social media post about the plight of Patrick Caputo has gone viral
During the COVID-19 lockdowns one global medical industry went into a partial deep freeze — the business of the face-to-face drug rep visit.
In Australia, pharmaceutical companies have generally invested some $330 million a year in these contacts with doctors, resulting in hundreds of thousands of visits.
